7-OH-DPAT Hydrobromide
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 527758

CAS#: 76135-30-3

Description: 7-OH-DPAT Hydrobromide is a potent and selective Dopamine D3 receptor agonist.


Chemical Structure

img
7-OH-DPAT Hydrobromide
CAS# 76135-30-3

Theoretical Analysis

MedKoo Cat#: 527758
Name: 7-OH-DPAT Hydrobromide
CAS#: 76135-30-3
Chemical Formula: C16H26BrNO
Exact Mass: 327.1198
Molecular Weight: 328.294
Elemental Analysis: C, 58.54; H, 7.98; Br, 24.34; N, 4.27; O, 4.87

Price and Availability

Size Price Availability Quantity
5.0mg USD 220.0 2 Weeks
10.0mg USD 360.0 2 Weeks
25.0mg USD 620.0 2 Weeks
Bulk inquiry

Synonym: 7-OH-DPAT Hydrobromide

IUPAC/Chemical Name: 7-Hydroxy-N,N-dipropyl-2-aminotetralin hydrobromide

InChi Key: ODNDMTWHRYECKX-UHFFFAOYSA-N

InChi Code: InChI=1S/C16H25NO.BrH/c1-3-9-17(10-4-2)15-7-5-13-6-8-16(18)12-14(13)11-15;/h6,8,12,15,18H,3-5,7,9-11H2,1-2H3;1H

SMILES Code: CCCN(CCC)C1CC2=C(C=CC(O)=C2)CC1.[H]Br

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 328.294 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Eguibar JR, Cortes Mdel C, Lara-Lozano M, Mendiola DM. Dopaminergic D2-like agonists produce yawning in the myelin mutant taiep and Sprague-Dawley rats. Pharmacol Biochem Behav. 2012 Jul;102(1):118-23. doi: 10.1016/j.pbb.2012.03.020. Epub 2012 Mar 31. PubMed PMID: 22497991.

2: Yoshizawa K, Narita M, Mori T, Miyatake M, Isotani K, Tomiyasu S, Tsukiyama Y, Suzuki T. Role of dopamine D2 and D3 receptors in mediating the U-50,488H discriminative cue: comparison with methamphetamine and cocaine. Addict Biol. 2012 Nov;17(6):949-55. doi: 10.1111/j.1369-1600.2010.00257.x. Epub 2010 Nov 4. PubMed PMID: 21054688.

3: Maina FK, Mathews TA. A functional fast scan cyclic voltammetry assay to characterize dopamine D2 and D3 autoreceptors in the mouse striatum. ACS Chem Neurosci. 2010 Mar 12;1(6):450-462. PubMed PMID: 20567609; PubMed Central PMCID: PMC2887711.

4: Everett PB, Senogles SE. D3 dopamine receptor signals to activation of phospholipase D through a complex with Rho. J Neurochem. 2010 Feb;112(4):963-71. doi: 10.1111/j.1471-4159.2009.06508.x. Epub 2009 Dec 18. PubMed PMID: 20021566.

5: Kitrey ND, Clément P, Bernabé J, Alexandre L, Giuliano F. Microinjection of the preferential dopamine receptor D3 agonist 7-hydroxy-N,N-di-n-propylaminotetralin hydrobromide into the hypothalamic medial preoptic area induced ejaculation in anesthetized rats. Neuroscience. 2007 Nov 9;149(3):636-41. Epub 2007 Jul 20. PubMed PMID: 17916409.

6: Ito S, Mori T, Sawaguchi T. Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice. Behav Pharmacol. 2006 Dec;17(8):691-701. PubMed PMID: 17110795.

7: Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior. J Pharmacol Exp Ther. 2005 Jul;314(1):310-9. Epub 2005 Apr 15. PubMed PMID: 15833897; PubMed Central PMCID: PMC1201434.

8: Rogóz Z, Skuza G, Kłlodzińska A. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats. Pol J Pharmacol. 2004 Sep-Oct;56(5):519-26. PubMed PMID: 15591639.

9: Cook CD, Beardsley PM. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists. Behav Pharmacol. 2004 Feb;15(1):75-83. PubMed PMID: 15075629.

10: Rogóz Z, Skuza G, Kłodzińska A. Anxiolytic-like effects of preferential dopamine D3 receptor agonists in an animal model. Pol J Pharmacol. 2003 May-Jun;55(3):449-54. PubMed PMID: 14506325.

11: Skuza G, Rogóz Z. A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist. Behav Pharmacol. 2002 Nov;13(7):537-43. PubMed PMID: 12409992.

12: Ottani A, Ferrari F, Giuliani D. Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):91-6. PubMed PMID: 11853125.

13: Levens N, Green TA, Akins CK, Bardo MT. Dopamine D(2)-like receptor binding in the brain of male Japanese quail (Coturnix japonica). Neurosci Lett. 2000 Dec 22;296(2-3):77-80. PubMed PMID: 11108985.

14: Dastur FN, McGregor IS, Brown RE. Dopaminergic modulation of rat pup ultrasonic vocalizations. Eur J Pharmacol. 1999 Oct 8;382(2):53-67. PubMed PMID: 10528139.

15: Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists. J Pharmacol Exp Ther. 1997 Oct;283(1):7-15. PubMed PMID: 9336302.

16: Mallet PE, Beninger RJ. 7-OH-DPAT produces place conditioning in rats. Eur J Pharmacol. 1994 Aug 22;261(3):R5-6. PubMed PMID: 7813542.